SolidWorld Group: the Electrospider 3D bioprinter protagonist in the 3D Innovation Lab of Humanitas University

Treviso, 26 November 2024 – SolidWorld Group S.p.A., a company listed on the Euronext Growth Milan market and at the head of the leading Group in the sectors of industrial design and 3D printing technologies, 3D bio-manufacturing and production lines of machinery for the manufacturing of latest generation photovoltaic panels, proudly announces the presence of the Electrospider 3D bioprinter among the leading technologies of the new 3D Innovation Lab, inaugurated yesterday by Humanitas University on the Campus of the Roberto Rocca Innovation Buildingin the province of Milan.
The 3D Innovation Lab, created to encourage contamination between clinical activity, scientific research and university education, aims to transform scientific discoveries into real solutions, applicable to the patient's bedside. Among the most advanced technologies available to the laboratory stands out Electrospider, a bioprinter patented globally by SolidWorld and developed by the subsidiary Bio3DPrinting together with the University of Pisa.
Electrospider: a revolution in 3D bioprinting
Electrospider represents a breakthrough in biomedical engineering and regenerative medicine. The aim of the bioprinter is to create complex structures of entire human organs, completely changing the quality of life of patients, shortening research times and improving the working methods of hospitals and healthcare facilities. The only 3D bioprinter in the world capable of recreating biological tissues compatible with humans thanks to the printing of innovative hydrogels loaded with the subject's cells, Electrospider can have various applications, including:
- regenerative medicine: development of tissues and organs for personalized transplants;
- oncology: creation of tissue models to test targeted therapies;
- pharmacology and cosmetics: safe tests on replicated human tissues;
The innovative 3D bioprinter is equipped with a proprietary Artificial Intelligence, developed by SolidWorld Group, which optimizes the biological printing process, ensuring precision and quality in the creation of tissue models.
A step forward in the medicine of the future
The integration of Electrospider into the 3D Innovation Lab of Humanitas University represents an important synergy between the academic world, research and industry. “Our goal is to support doctors and researchers in developing solutions that improve the quality of life of patients and accelerate progress in regenerative medicine,” comments Roberto Rizzo, President and CEO of SolidWorld Group.
***
SolidWorld Group S.p.A.is the head of a group of 10 companies active in the industrial, biomedical and solar pillars founded in the early 2000s by the engineer Roberto Rizzo. Listed since 6 July 2022 on the Euronext Growth Milan segment of the Italian Stock Exchange (ticker S3D), the Group is a leader in the development and The objective of Electrospider, in fact, is to create complex structures of entire human organs, completely changing the quality of life of patients, shortening research times (just think of the testing of a cure which, through the use of Electrospider, is now possible directly in the patient's in vitro cells) and improving the working methods of hospitals and facilities healthcare. integration of the most modern and complete 3D digital technologies, in the software and hardware fields, within manufacturing companies to support and accelerate their transformation towards Factory 5.0. Thanks to SolidWorld, all production phases of a product, up to its sale and recycling, are integrated thanks to technologies that make the production process faster, more sustainable and efficient. It operates through 16 offices and 3 technological hubs, has over 220 employees and more than 10 thousand client companies. In 2023, the acquisition of Valore BF 3d S.r.l. was completed. thanks to which SolidWorld acquired a new customer base. The transfer of a technological business unit by the company Formula E S.r.l., a company of the Vismunda S.r.l. group, a world leader in automation for equipment dedicated to the renewable energy sector which has allowed SolidWorld Group to enter the solar market, was completed in 2023. In the first half of 2024, the SolidWorld Group recorded revenues of 30.9 million euros, a production value of 40.1 million euros with an EBITDA of 6.3 million euros. www.solidworldgroup.it/en
CONTACTS
Investor Relations Manager
Elisabetta Cammarata
investor@solidworld.it
IR & Corporate Media Advisor
TWIN
solidworld@twin.services
Federico Bagatella | T. +39 331 8007258
Morena Azzi | T. +39 331 1070477
Request an appointment, fill out the form:
Related posts

Electrospider and the future of 3D bioprinting at 3DEXPERIENCE WORLD 2025
3D bioprinting opens new frontiers in regenerative medicine: the Electrospider case at 3DEXPERIENCE WORLD 2025

Electrospider Workshop: an immersion in the multi-scale and multi-material bioprinting ecosystem
A high-level meeting to explore the potential of bioprinting in research laboratories.

3D bioprinting revolutionizes medicine
3D printing of diseased organs opens new frontiers in surgery: Electrospider’s contribution to humanitas’ medical research